HK2 and hepatocellular carcinoma: The AKT/mTOR pathway is known to interfere with aerobic glycolysis regulating three limiting enzymes in the glycolytic pathway (hexokinase 2, phosphofructokinase 1, and pyruvate kinases type M2), a fact that is crucial for HCC progression [54,55,56,57].